nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Nail disorder—Mesalazine—Crohn's disease	0.00923	0.00927	CcSEcCtD
Doxazosin—Parosmia—Mesalazine—Crohn's disease	0.00923	0.00927	CcSEcCtD
Doxazosin—Herpes zoster—Azathioprine—Crohn's disease	0.00873	0.00877	CcSEcCtD
Doxazosin—Cholestasis—Azathioprine—Crohn's disease	0.00866	0.00869	CcSEcCtD
Doxazosin—Epilepsy—Prednisone—Crohn's disease	0.00834	0.00837	CcSEcCtD
Doxazosin—Tongue disorder—Mesalazine—Crohn's disease	0.00824	0.00827	CcSEcCtD
Doxazosin—Rigors—Azathioprine—Crohn's disease	0.00805	0.00809	CcSEcCtD
Doxazosin—Cholestasis—Mesalazine—Crohn's disease	0.00789	0.00792	CcSEcCtD
Doxazosin—Scotoma—Mesalazine—Crohn's disease	0.00789	0.00792	CcSEcCtD
Doxazosin—Rash erythematous—Mesalazine—Crohn's disease	0.00782	0.00785	CcSEcCtD
Doxazosin—Neoplasm malignant—Azathioprine—Crohn's disease	0.0077	0.00773	CcSEcCtD
Doxazosin—Breast pain—Mesalazine—Crohn's disease	0.00686	0.00689	CcSEcCtD
Doxazosin—Rectal haemorrhage—Mesalazine—Crohn's disease	0.00663	0.00666	CcSEcCtD
Doxazosin—Gout—Mesalazine—Crohn's disease	0.00641	0.00644	CcSEcCtD
Doxazosin—Melaena—Mesalazine—Crohn's disease	0.00585	0.00587	CcSEcCtD
Doxazosin—Cystitis noninfective—Mesalazine—Crohn's disease	0.00585	0.00587	CcSEcCtD
Doxazosin—Influenza like illness—Mesalazine—Crohn's disease	0.00582	0.00584	CcSEcCtD
Doxazosin—Cystitis—Mesalazine—Crohn's disease	0.00578	0.00581	CcSEcCtD
Doxazosin—Cramps of lower extremities—Mesalazine—Crohn's disease	0.0055	0.00552	CcSEcCtD
Doxazosin—Bladder pain—Mesalazine—Crohn's disease	0.00542	0.00544	CcSEcCtD
Doxazosin—Hypertonia—Mesalazine—Crohn's disease	0.00525	0.00527	CcSEcCtD
Doxazosin—Lymphadenopathy—Mesalazine—Crohn's disease	0.0051	0.00512	CcSEcCtD
Doxazosin—Ear pain—Mesalazine—Crohn's disease	0.0051	0.00512	CcSEcCtD
Doxazosin—Gastroenteritis—Mesalazine—Crohn's disease	0.00491	0.00493	CcSEcCtD
Doxazosin—Alopecia—Mercaptopurine—Crohn's disease	0.0049	0.00492	CcSEcCtD
Doxazosin—Deafness—Mesalazine—Crohn's disease	0.00486	0.00488	CcSEcCtD
Doxazosin—Eczema—Mesalazine—Crohn's disease	0.00484	0.00486	CcSEcCtD
Doxazosin—Malnutrition—Mercaptopurine—Crohn's disease	0.00482	0.00484	CcSEcCtD
Doxazosin—Eye pain—Mesalazine—Crohn's disease	0.00482	0.00484	CcSEcCtD
Doxazosin—Libido decreased—Mesalazine—Crohn's disease	0.00469	0.00471	CcSEcCtD
Doxazosin—Increased appetite—Mesalazine—Crohn's disease	0.00463	0.00465	CcSEcCtD
Doxazosin—Atrial fibrillation—Mesalazine—Crohn's disease	0.00459	0.00461	CcSEcCtD
Doxazosin—Thirst—Mesalazine—Crohn's disease	0.00457	0.00459	CcSEcCtD
Doxazosin—Arthritis—Mesalazine—Crohn's disease	0.00447	0.00449	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00435	0.00437	CcSEcCtD
Doxazosin—Leukopenia—Mercaptopurine—Crohn's disease	0.00432	0.00434	CcSEcCtD
Doxazosin—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00431	0.00433	CcSEcCtD
Doxazosin—Migraine—Mesalazine—Crohn's disease	0.00428	0.0043	CcSEcCtD
Doxazosin—Affect lability—Mesalazine—Crohn's disease	0.00428	0.0043	CcSEcCtD
Doxazosin—Face oedema—Mesalazine—Crohn's disease	0.0042	0.00421	CcSEcCtD
Doxazosin—Mood swings—Mesalazine—Crohn's disease	0.00412	0.00414	CcSEcCtD
Doxazosin—Arthralgia—Mercaptopurine—Crohn's disease	0.00411	0.00412	CcSEcCtD
Doxazosin—Fungal infection—Prednisone—Crohn's disease	0.0041	0.00412	CcSEcCtD
Doxazosin—Liver function test abnormal—Mesalazine—Crohn's disease	0.00401	0.00403	CcSEcCtD
Doxazosin—Dry skin—Mesalazine—Crohn's disease	0.00399	0.004	CcSEcCtD
Doxazosin—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00397	0.00399	CcSEcCtD
Doxazosin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00395	0.00397	CcSEcCtD
Doxazosin—Oedema—Mercaptopurine—Crohn's disease	0.00394	0.00395	CcSEcCtD
Doxazosin—Cramp muscle—Mesalazine—Crohn's disease	0.00392	0.00393	CcSEcCtD
Doxazosin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00385	0.00387	CcSEcCtD
Doxazosin—Skin disorder—Mercaptopurine—Crohn's disease	0.00382	0.00384	CcSEcCtD
Doxazosin—Abdominal distension—Mesalazine—Crohn's disease	0.00378	0.0038	CcSEcCtD
Doxazosin—Anorexia—Mercaptopurine—Crohn's disease	0.00375	0.00377	CcSEcCtD
Doxazosin—Pneumonia—Azathioprine—Crohn's disease	0.0037	0.00371	CcSEcCtD
Doxazosin—Bronchospasm—Mesalazine—Crohn's disease	0.0037	0.00371	CcSEcCtD
Doxazosin—Angina pectoris—Mesalazine—Crohn's disease	0.00366	0.00368	CcSEcCtD
Doxazosin—Bronchitis—Mesalazine—Crohn's disease	0.00361	0.00363	CcSEcCtD
Doxazosin—Abdominal discomfort—Mesalazine—Crohn's disease	0.0036	0.00362	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00359	0.0036	CcSEcCtD
Doxazosin—Dysuria—Mesalazine—Crohn's disease	0.00351	0.00353	CcSEcCtD
Doxazosin—Neutropenia—Mesalazine—Crohn's disease	0.00351	0.00353	CcSEcCtD
Doxazosin—Viral infection—Prednisone—Crohn's disease	0.00351	0.00352	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00349	0.00351	CcSEcCtD
Doxazosin—Pollakiuria—Mesalazine—Crohn's disease	0.00347	0.00349	CcSEcCtD
Doxazosin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00343	0.00344	CcSEcCtD
Doxazosin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00342	0.00344	CcSEcCtD
Doxazosin—Weight increased—Mesalazine—Crohn's disease	0.00342	0.00343	CcSEcCtD
Doxazosin—Weight decreased—Mesalazine—Crohn's disease	0.0034	0.00341	CcSEcCtD
Doxazosin—Pneumonia—Mesalazine—Crohn's disease	0.00337	0.00338	CcSEcCtD
Doxazosin—Depression—Mesalazine—Crohn's disease	0.00334	0.00335	CcSEcCtD
Doxazosin—Cataract—Prednisone—Crohn's disease	0.00333	0.00334	CcSEcCtD
Doxazosin—Jaundice—Mesalazine—Crohn's disease	0.00327	0.00328	CcSEcCtD
Doxazosin—Urinary tract infection—Mesalazine—Crohn's disease	0.00326	0.00327	CcSEcCtD
Doxazosin—Conjunctivitis—Mesalazine—Crohn's disease	0.00326	0.00327	CcSEcCtD
Doxazosin—Sweating—Mesalazine—Crohn's disease	0.00321	0.00322	CcSEcCtD
Doxazosin—Haematuria—Mesalazine—Crohn's disease	0.00319	0.00321	CcSEcCtD
Doxazosin—Epistaxis—Mesalazine—Crohn's disease	0.00316	0.00317	CcSEcCtD
Doxazosin—Sinusitis—Mesalazine—Crohn's disease	0.00314	0.00316	CcSEcCtD
Doxazosin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00311	0.00312	CcSEcCtD
Doxazosin—Rhinitis—Mesalazine—Crohn's disease	0.00302	0.00303	CcSEcCtD
Doxazosin—Hepatitis—Mesalazine—Crohn's disease	0.00301	0.00302	CcSEcCtD
Doxazosin—Pharyngitis—Mesalazine—Crohn's disease	0.00299	0.003	CcSEcCtD
Doxazosin—Chills—Azathioprine—Crohn's disease	0.00296	0.00297	CcSEcCtD
Doxazosin—Arrhythmia—Azathioprine—Crohn's disease	0.00295	0.00296	CcSEcCtD
Doxazosin—Alopecia—Azathioprine—Crohn's disease	0.00292	0.00293	CcSEcCtD
Doxazosin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.0029	0.00291	CcSEcCtD
Doxazosin—Oesophagitis—Prednisone—Crohn's disease	0.0029	0.00291	CcSEcCtD
Doxazosin—Eye disorder—Mesalazine—Crohn's disease	0.00281	0.00282	CcSEcCtD
Doxazosin—Tinnitus—Mesalazine—Crohn's disease	0.0028	0.00282	CcSEcCtD
Doxazosin—Sepsis—Prednisone—Crohn's disease	0.00275	0.00276	CcSEcCtD
Doxazosin—Chills—Mesalazine—Crohn's disease	0.0027	0.00271	CcSEcCtD
Doxazosin—Diarrhoea—Mercaptopurine—Crohn's disease	0.00269	0.0027	CcSEcCtD
Doxazosin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00267	0.00268	CcSEcCtD
Doxazosin—Alopecia—Mesalazine—Crohn's disease	0.00266	0.00267	CcSEcCtD
Doxazosin—Mental disorder—Mesalazine—Crohn's disease	0.00264	0.00265	CcSEcCtD
Doxazosin—Malaise—Azathioprine—Crohn's disease	0.00259	0.0026	CcSEcCtD
Doxazosin—Flatulence—Mesalazine—Crohn's disease	0.00258	0.00259	CcSEcCtD
Doxazosin—Leukopenia—Azathioprine—Crohn's disease	0.00257	0.00258	CcSEcCtD
Doxazosin—Vascular purpura—Prednisone—Crohn's disease	0.00257	0.00258	CcSEcCtD
Doxazosin—Tension—Mesalazine—Crohn's disease	0.00257	0.00258	CcSEcCtD
Doxazosin—Dysgeusia—Mesalazine—Crohn's disease	0.00256	0.00257	CcSEcCtD
Doxazosin—Nervousness—Mesalazine—Crohn's disease	0.00254	0.00255	CcSEcCtD
Doxazosin—Back pain—Mesalazine—Crohn's disease	0.00253	0.00254	CcSEcCtD
Doxazosin—Muscle spasms—Mesalazine—Crohn's disease	0.00252	0.00253	CcSEcCtD
Doxazosin—Vomiting—Mercaptopurine—Crohn's disease	0.0025	0.00251	CcSEcCtD
Doxazosin—Rash—Mercaptopurine—Crohn's disease	0.00248	0.00249	CcSEcCtD
Doxazosin—Dermatitis—Mercaptopurine—Crohn's disease	0.00248	0.00249	CcSEcCtD
Doxazosin—Vision blurred—Mesalazine—Crohn's disease	0.00247	0.00248	CcSEcCtD
Doxazosin—Tremor—Mesalazine—Crohn's disease	0.00245	0.00246	CcSEcCtD
Doxazosin—Increased appetite—Prednisone—Crohn's disease	0.00245	0.00246	CcSEcCtD
Doxazosin—Amnesia—Prednisone—Crohn's disease	0.00245	0.00246	CcSEcCtD
Doxazosin—Myalgia—Azathioprine—Crohn's disease	0.00245	0.00246	CcSEcCtD
Doxazosin—Arthralgia—Azathioprine—Crohn's disease	0.00245	0.00246	CcSEcCtD
Doxazosin—Ill-defined disorder—Mesalazine—Crohn's disease	0.00243	0.00244	CcSEcCtD
Doxazosin—Discomfort—Azathioprine—Crohn's disease	0.00242	0.00243	CcSEcCtD
Doxazosin—Purpura—Prednisone—Crohn's disease	0.00239	0.0024	CcSEcCtD
Doxazosin—Malaise—Mesalazine—Crohn's disease	0.00236	0.00237	CcSEcCtD
Doxazosin—Cardiac failure—Prednisone—Crohn's disease	0.00236	0.00237	CcSEcCtD
Doxazosin—Vertigo—Mesalazine—Crohn's disease	0.00235	0.00236	CcSEcCtD
Doxazosin—Syncope—Mesalazine—Crohn's disease	0.00235	0.00236	CcSEcCtD
Doxazosin—Leukopenia—Mesalazine—Crohn's disease	0.00234	0.00235	CcSEcCtD
Doxazosin—Nausea—Mercaptopurine—Crohn's disease	0.00234	0.00235	CcSEcCtD
Doxazosin—Infection—Azathioprine—Crohn's disease	0.00233	0.00234	CcSEcCtD
Doxazosin—Palpitations—Mesalazine—Crohn's disease	0.00231	0.00232	CcSEcCtD
Doxazosin—Loss of consciousness—Mesalazine—Crohn's disease	0.0023	0.00231	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.0023	0.00231	CcSEcCtD
Doxazosin—Thrombocytopenia—Azathioprine—Crohn's disease	0.0023	0.00231	CcSEcCtD
Doxazosin—Cough—Mesalazine—Crohn's disease	0.00228	0.00229	CcSEcCtD
Doxazosin—Skin disorder—Azathioprine—Crohn's disease	0.00228	0.00229	CcSEcCtD
Doxazosin—Affect lability—Prednisone—Crohn's disease	0.00226	0.00227	CcSEcCtD
Doxazosin—Hypertension—Mesalazine—Crohn's disease	0.00226	0.00227	CcSEcCtD
Doxazosin—Arthralgia—Mesalazine—Crohn's disease	0.00223	0.00224	CcSEcCtD
Doxazosin—Chest pain—Mesalazine—Crohn's disease	0.00223	0.00224	CcSEcCtD
Doxazosin—Myalgia—Mesalazine—Crohn's disease	0.00223	0.00224	CcSEcCtD
Doxazosin—Anxiety—Mesalazine—Crohn's disease	0.00222	0.00223	CcSEcCtD
Doxazosin—Face oedema—Prednisone—Crohn's disease	0.00222	0.00223	CcSEcCtD
Doxazosin—Discomfort—Mesalazine—Crohn's disease	0.0022	0.00221	CcSEcCtD
Doxazosin—Hypotension—Azathioprine—Crohn's disease	0.00219	0.0022	CcSEcCtD
Doxazosin—Dry mouth—Mesalazine—Crohn's disease	0.00218	0.00219	CcSEcCtD
Doxazosin—Mood swings—Prednisone—Crohn's disease	0.00218	0.00219	CcSEcCtD
Doxazosin—Confusional state—Mesalazine—Crohn's disease	0.00215	0.00216	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00214	0.00215	CcSEcCtD
Doxazosin—Oedema—Mesalazine—Crohn's disease	0.00214	0.00215	CcSEcCtD
Doxazosin—Infection—Mesalazine—Crohn's disease	0.00212	0.00213	CcSEcCtD
Doxazosin—Dry skin—Prednisone—Crohn's disease	0.00211	0.00212	CcSEcCtD
Doxazosin—Shock—Mesalazine—Crohn's disease	0.0021	0.00211	CcSEcCtD
Doxazosin—Hypokalaemia—Prednisone—Crohn's disease	0.00209	0.0021	CcSEcCtD
Doxazosin—Thrombocytopenia—Mesalazine—Crohn's disease	0.00209	0.0021	CcSEcCtD
Doxazosin—Tachycardia—Mesalazine—Crohn's disease	0.00209	0.00209	CcSEcCtD
Doxazosin—Skin disorder—Mesalazine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Doxazosin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00207	0.00207	CcSEcCtD
Doxazosin—Anorexia—Mesalazine—Crohn's disease	0.00204	0.00205	CcSEcCtD
Doxazosin—Muscular weakness—Prednisone—Crohn's disease	0.00203	0.00204	CcSEcCtD
Doxazosin—Abdominal distension—Prednisone—Crohn's disease	0.002	0.00201	CcSEcCtD
Doxazosin—Hypotension—Mesalazine—Crohn's disease	0.002	0.002	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00195	0.00195	CcSEcCtD
Doxazosin—Sweating increased—Prednisone—Crohn's disease	0.00194	0.00194	CcSEcCtD
Doxazosin—Feeling abnormal—Azathioprine—Crohn's disease	0.00193	0.00194	CcSEcCtD
Doxazosin—Insomnia—Mesalazine—Crohn's disease	0.00193	0.00194	CcSEcCtD
Doxazosin—Paraesthesia—Mesalazine—Crohn's disease	0.00192	0.00193	CcSEcCtD
Doxazosin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00192	0.00193	CcSEcCtD
Doxazosin—Dyspnoea—Mesalazine—Crohn's disease	0.00191	0.00191	CcSEcCtD
Doxazosin—Somnolence—Mesalazine—Crohn's disease	0.0019	0.00191	CcSEcCtD
Doxazosin—Dyspepsia—Mesalazine—Crohn's disease	0.00188	0.00189	CcSEcCtD
Doxazosin—Neutropenia—Prednisone—Crohn's disease	0.00186	0.00187	CcSEcCtD
Doxazosin—Decreased appetite—Mesalazine—Crohn's disease	0.00186	0.00187	CcSEcCtD
Doxazosin—Body temperature increased—Azathioprine—Crohn's disease	0.00185	0.00186	CcSEcCtD
Doxazosin—Abdominal pain—Azathioprine—Crohn's disease	0.00185	0.00186	CcSEcCtD
Doxazosin—Fatigue—Mesalazine—Crohn's disease	0.00184	0.00185	CcSEcCtD
Doxazosin—Erectile dysfunction—Prednisone—Crohn's disease	0.00183	0.00184	CcSEcCtD
Doxazosin—Pain—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Doxazosin—Constipation—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Doxazosin—Weight increased—Prednisone—Crohn's disease	0.00181	0.00182	CcSEcCtD
Doxazosin—Weight decreased—Prednisone—Crohn's disease	0.0018	0.00181	CcSEcCtD
Doxazosin—Hyperglycaemia—Prednisone—Crohn's disease	0.00179	0.0018	CcSEcCtD
Doxazosin—Depression—Prednisone—Crohn's disease	0.00177	0.00177	CcSEcCtD
Doxazosin—Feeling abnormal—Mesalazine—Crohn's disease	0.00176	0.00177	CcSEcCtD
Doxazosin—Acute coronary syndrome—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Doxazosin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00175	0.00175	CcSEcCtD
Doxazosin—Myocardial infarction—Prednisone—Crohn's disease	0.00174	0.00174	CcSEcCtD
Doxazosin—Hypersensitivity—Azathioprine—Crohn's disease	0.00173	0.00174	CcSEcCtD
Doxazosin—Urticaria—Mesalazine—Crohn's disease	0.0017	0.0017	CcSEcCtD
Doxazosin—Body temperature increased—Mesalazine—Crohn's disease	0.00169	0.0017	CcSEcCtD
Doxazosin—Abdominal pain—Mesalazine—Crohn's disease	0.00169	0.0017	CcSEcCtD
Doxazosin—Bradycardia—Prednisone—Crohn's disease	0.00162	0.00163	CcSEcCtD
Doxazosin—Diarrhoea—Azathioprine—Crohn's disease	0.00161	0.00161	CcSEcCtD
Doxazosin—Hypersensitivity—Mesalazine—Crohn's disease	0.00157	0.00158	CcSEcCtD
Doxazosin—Dizziness—Azathioprine—Crohn's disease	0.00155	0.00156	CcSEcCtD
Doxazosin—Asthenia—Mesalazine—Crohn's disease	0.00153	0.00154	CcSEcCtD
Doxazosin—Pruritus—Mesalazine—Crohn's disease	0.00151	0.00152	CcSEcCtD
Doxazosin—Vomiting—Azathioprine—Crohn's disease	0.00149	0.0015	CcSEcCtD
Doxazosin—Eye disorder—Prednisone—Crohn's disease	0.00149	0.00149	CcSEcCtD
Doxazosin—Rash—Azathioprine—Crohn's disease	0.00148	0.00149	CcSEcCtD
Doxazosin—Dermatitis—Azathioprine—Crohn's disease	0.00148	0.00148	CcSEcCtD
Doxazosin—Flushing—Prednisone—Crohn's disease	0.00148	0.00148	CcSEcCtD
Doxazosin—Headache—Azathioprine—Crohn's disease	0.00147	0.00148	CcSEcCtD
Doxazosin—Diarrhoea—Mesalazine—Crohn's disease	0.00146	0.00147	CcSEcCtD
Doxazosin—Arrhythmia—Prednisone—Crohn's disease	0.00142	0.00143	CcSEcCtD
Doxazosin—Dizziness—Mesalazine—Crohn's disease	0.00141	0.00142	CcSEcCtD
Doxazosin—Alopecia—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Doxazosin—Mental disorder—Prednisone—Crohn's disease	0.00139	0.0014	CcSEcCtD
Doxazosin—Nausea—Azathioprine—Crohn's disease	0.00139	0.0014	CcSEcCtD
Doxazosin—Malnutrition—Prednisone—Crohn's disease	0.00139	0.00139	CcSEcCtD
Doxazosin—Vomiting—Mesalazine—Crohn's disease	0.00136	0.00136	CcSEcCtD
Doxazosin—Rash—Mesalazine—Crohn's disease	0.00135	0.00135	CcSEcCtD
Doxazosin—Dermatitis—Mesalazine—Crohn's disease	0.00135	0.00135	CcSEcCtD
Doxazosin—Headache—Mesalazine—Crohn's disease	0.00134	0.00134	CcSEcCtD
Doxazosin—Vision blurred—Prednisone—Crohn's disease	0.00131	0.00131	CcSEcCtD
Doxazosin—Ill-defined disorder—Prednisone—Crohn's disease	0.00129	0.00129	CcSEcCtD
Doxazosin—Agitation—Prednisone—Crohn's disease	0.00127	0.00128	CcSEcCtD
Doxazosin—Nausea—Mesalazine—Crohn's disease	0.00127	0.00127	CcSEcCtD
Doxazosin—Malaise—Prednisone—Crohn's disease	0.00125	0.00125	CcSEcCtD
Doxazosin—Vertigo—Prednisone—Crohn's disease	0.00124	0.00125	CcSEcCtD
Doxazosin—Syncope—Prednisone—Crohn's disease	0.00124	0.00125	CcSEcCtD
Doxazosin—Loss of consciousness—Prednisone—Crohn's disease	0.00122	0.00122	CcSEcCtD
Doxazosin—Convulsion—Prednisone—Crohn's disease	0.0012	0.00121	CcSEcCtD
Doxazosin—Hypertension—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Doxazosin—Myalgia—Prednisone—Crohn's disease	0.00118	0.00118	CcSEcCtD
Doxazosin—Arthralgia—Prednisone—Crohn's disease	0.00118	0.00118	CcSEcCtD
Doxazosin—Anxiety—Prednisone—Crohn's disease	0.00118	0.00118	CcSEcCtD
Doxazosin—Discomfort—Prednisone—Crohn's disease	0.00117	0.00117	CcSEcCtD
Doxazosin—Oedema—Prednisone—Crohn's disease	0.00113	0.00114	CcSEcCtD
Doxazosin—Infection—Prednisone—Crohn's disease	0.00112	0.00113	CcSEcCtD
Doxazosin—Shock—Prednisone—Crohn's disease	0.00111	0.00112	CcSEcCtD
Doxazosin—Tachycardia—Prednisone—Crohn's disease	0.0011	0.00111	CcSEcCtD
Doxazosin—Skin disorder—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Doxazosin—Hyperhidrosis—Prednisone—Crohn's disease	0.00109	0.0011	CcSEcCtD
Doxazosin—Anorexia—Prednisone—Crohn's disease	0.00108	0.00108	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00103	0.00103	CcSEcCtD
Doxazosin—Insomnia—Prednisone—Crohn's disease	0.00102	0.00103	CcSEcCtD
Doxazosin—Paraesthesia—Prednisone—Crohn's disease	0.00102	0.00102	CcSEcCtD
Doxazosin—Dyspepsia—Prednisone—Crohn's disease	0.000995	0.000999	CcSEcCtD
Doxazosin—Decreased appetite—Prednisone—Crohn's disease	0.000983	0.000987	CcSEcCtD
Doxazosin—Fatigue—Prednisone—Crohn's disease	0.000975	0.000979	CcSEcCtD
Doxazosin—Constipation—Prednisone—Crohn's disease	0.000967	0.000971	CcSEcCtD
Doxazosin—Feeling abnormal—Prednisone—Crohn's disease	0.000932	0.000935	CcSEcCtD
Doxazosin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000924	0.000928	CcSEcCtD
Doxazosin—Urticaria—Prednisone—Crohn's disease	0.000898	0.000902	CcSEcCtD
Doxazosin—Abdominal pain—Prednisone—Crohn's disease	0.000894	0.000897	CcSEcCtD
Doxazosin—Body temperature increased—Prednisone—Crohn's disease	0.000894	0.000897	CcSEcCtD
Doxazosin—Hypersensitivity—Prednisone—Crohn's disease	0.000833	0.000836	CcSEcCtD
Doxazosin—Asthenia—Prednisone—Crohn's disease	0.000811	0.000814	CcSEcCtD
Doxazosin—Pruritus—Prednisone—Crohn's disease	0.0008	0.000803	CcSEcCtD
Doxazosin—Diarrhoea—Prednisone—Crohn's disease	0.000774	0.000777	CcSEcCtD
Doxazosin—Dizziness—Prednisone—Crohn's disease	0.000748	0.000751	CcSEcCtD
Doxazosin—Vomiting—Prednisone—Crohn's disease	0.000719	0.000722	CcSEcCtD
Doxazosin—Rash—Prednisone—Crohn's disease	0.000713	0.000716	CcSEcCtD
Doxazosin—Dermatitis—Prednisone—Crohn's disease	0.000712	0.000715	CcSEcCtD
Doxazosin—Headache—Prednisone—Crohn's disease	0.000708	0.000711	CcSEcCtD
Doxazosin—Nausea—Prednisone—Crohn's disease	0.000672	0.000674	CcSEcCtD
Doxazosin—ADRA1D—GPCR downstream signaling—GPR65—Crohn's disease	9.58e-06	0.00239	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	9.56e-06	0.00238	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.5e-06	0.00237	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCR9—Crohn's disease	9.36e-06	0.00233	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—F5—Crohn's disease	9.25e-06	0.0023	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MLN—Crohn's disease	9.25e-06	0.0023	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CCR6—Crohn's disease	8.9e-06	0.00222	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—PTGER4—Crohn's disease	8.82e-06	0.0022	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—GPR65—Crohn's disease	8.7e-06	0.00217	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—TNF—Crohn's disease	8.63e-06	0.00215	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CCR9—Crohn's disease	8.55e-06	0.00213	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ACKR2—Crohn's disease	8.41e-06	0.0021	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	8.36e-06	0.00208	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CCR6—Crohn's disease	8.27e-06	0.00206	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.08e-06	0.00201	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MLN—Crohn's disease	7.97e-06	0.00199	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—GPR65—Crohn's disease	7.95e-06	0.00198	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	7.93e-06	0.00197	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—PTGER4—Crohn's disease	7.84e-06	0.00195	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	7.83e-06	0.00195	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCR9—Crohn's disease	7.77e-06	0.00193	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CCR9—Crohn's disease	7.6e-06	0.00189	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	7.56e-06	0.00188	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	7.54e-06	0.00188	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.5e-06	0.00187	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.5e-06	0.00187	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TAGAP—Crohn's disease	7.29e-06	0.00182	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—PTGER4—Crohn's disease	7.28e-06	0.00181	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	7.28e-06	0.00181	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—GPR65—Crohn's disease	7.22e-06	0.0018	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	7.06e-06	0.00176	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CCR9—Crohn's disease	7.06e-06	0.00176	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.99e-06	0.00174	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ACKR2—Crohn's disease	6.98e-06	0.00174	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—IL6—Crohn's disease	6.96e-06	0.00173	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	6.9e-06	0.00172	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CCR6—Crohn's disease	6.82e-06	0.0017	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MLN—Crohn's disease	6.62e-06	0.00165	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	6.58e-06	0.00164	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—GPR65—Crohn's disease	6.56e-06	0.00163	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	6.41e-06	0.0016	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCR9—Crohn's disease	6.41e-06	0.0016	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RSPO3—Crohn's disease	6.37e-06	0.00159	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.3e-06	0.00157	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	6.28e-06	0.00156	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	6.2e-06	0.00154	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCR6—Crohn's disease	6.2e-06	0.00154	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TAGAP—Crohn's disease	6.05e-06	0.00151	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SEL1L—Crohn's disease	6.04e-06	0.00151	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PTGER4—Crohn's disease	6.01e-06	0.0015	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PLA2G4F—Crohn's disease	5.97e-06	0.00149	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—GPR65—Crohn's disease	5.96e-06	0.00148	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.9e-06	0.00147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MLN—Crohn's disease	5.88e-06	0.00146	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.84e-06	0.00146	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ACKR2—Crohn's disease	5.76e-06	0.00144	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ITGA4—Crohn's disease	5.69e-06	0.00142	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CCR6—Crohn's disease	5.66e-06	0.00141	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.57e-06	0.00139	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL3—Crohn's disease	5.55e-06	0.00138	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCR9—Crohn's disease	5.53e-06	0.00138	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MLN—Crohn's disease	5.46e-06	0.00136	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PTGER4—Crohn's disease	5.46e-06	0.00136	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	5.45e-06	0.00136	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	5.38e-06	0.00134	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	5.37e-06	0.00134	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RSPO3—Crohn's disease	5.29e-06	0.00132	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.28e-06	0.00132	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCR6—Crohn's disease	5.14e-06	0.00128	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GPR65—Crohn's disease	5.14e-06	0.00128	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL3—Crohn's disease	5.12e-06	0.00127	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	5.11e-06	0.00127	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTMR3—Crohn's disease	5.08e-06	0.00127	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TNF—Crohn's disease	5.07e-06	0.00126	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	5.07e-06	0.00126	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	5.03e-06	0.00125	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SEL1L—Crohn's disease	5.02e-06	0.00125	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	5e-06	0.00124	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PTGER4—Crohn's disease	4.99e-06	0.00124	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—RASGRP1—Crohn's disease	4.95e-06	0.00123	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	4.7e-06	0.00117	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	4.67e-06	0.00116	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.67e-06	0.00116	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL3—Crohn's disease	4.65e-06	0.00116	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR9—Crohn's disease	4.59e-06	0.00114	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	4.57e-06	0.00114	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PTGER4—Crohn's disease	4.53e-06	0.00113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RASGRP1—Crohn's disease	4.5e-06	0.00112	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	4.45e-06	0.00111	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	4.43e-06	0.0011	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	4.4e-06	0.0011	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	4.37e-06	0.00109	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GPR65—Crohn's disease	4.26e-06	0.00106	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL3—Crohn's disease	4.25e-06	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	4.25e-06	0.00106	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.24e-06	0.00106	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.23e-06	0.00105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	4.14e-06	0.00103	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	4.13e-06	0.00103	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	4.12e-06	0.00103	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—RASGRP1—Crohn's disease	4.11e-06	0.00102	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	4.07e-06	0.00101	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	4.02e-06	0.001	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—FADS1—Crohn's disease	3.96e-06	0.000986	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.89e-06	0.00097	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—CXCL8—Crohn's disease	3.89e-06	0.000969	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2RA—Crohn's disease	3.89e-06	0.000968	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.88e-06	0.000966	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL3—Crohn's disease	3.86e-06	0.000961	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	3.79e-06	0.000944	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	3.79e-06	0.000943	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	3.77e-06	0.00094	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.77e-06	0.000938	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	3.74e-06	0.000931	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RASGRP1—Crohn's disease	3.73e-06	0.000929	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX4—Crohn's disease	3.71e-06	0.000923	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.71e-06	0.000923	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCR6—Crohn's disease	3.66e-06	0.000912	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.65e-06	0.000909	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.6e-06	0.000896	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2RA—Crohn's disease	3.59e-06	0.000893	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GCKR—Crohn's disease	3.58e-06	0.000891	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	3.52e-06	0.000877	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTMR3—Crohn's disease	3.51e-06	0.000875	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	3.51e-06	0.000873	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.5e-06	0.000872	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	3.43e-06	0.000853	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.39e-06	0.000845	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	3.31e-06	0.000825	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RBX1—Crohn's disease	3.31e-06	0.000825	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.31e-06	0.000825	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2RA—Crohn's disease	3.26e-06	0.000811	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	3.23e-06	0.000805	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	3.22e-06	0.000803	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.22e-06	0.000801	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	3.18e-06	0.000793	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	3.08e-06	0.000767	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	3.04e-06	0.000757	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	2.98e-06	0.000741	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	2.9e-06	0.000723	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	2.87e-06	0.000715	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.86e-06	0.000712	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	2.82e-06	0.000701	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ALB—Crohn's disease	2.81e-06	0.0007	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—FADS1—Crohn's disease	2.8e-06	0.000698	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	2.75e-06	0.000685	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL3—Crohn's disease	2.75e-06	0.000684	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—FADS1—Crohn's disease	2.74e-06	0.000682	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	2.7e-06	0.000673	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	2.7e-06	0.000672	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	2.68e-06	0.000666	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	2.67e-06	0.000664	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	2.66e-06	0.000661	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	2.64e-06	0.000658	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX4—Crohn's disease	2.63e-06	0.000654	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—JAK2—Crohn's disease	2.61e-06	0.000651	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—FADS1—Crohn's disease	2.58e-06	0.000642	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX4—Crohn's disease	2.56e-06	0.000638	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GCKR—Crohn's disease	2.54e-06	0.000632	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	2.51e-06	0.000625	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.5e-06	0.000623	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GCKR—Crohn's disease	2.47e-06	0.000616	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	2.46e-06	0.000612	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	2.44e-06	0.000608	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX4—Crohn's disease	2.41e-06	0.000601	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	2.41e-06	0.0006	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	2.41e-06	0.0006	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	2.41e-06	0.000599	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	2.4e-06	0.000598	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	2.38e-06	0.000592	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	2.34e-06	0.000582	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCKR—Crohn's disease	2.33e-06	0.000581	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	2.29e-06	0.000571	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL3—Crohn's disease	2.28e-06	0.000568	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	2.27e-06	0.000565	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	2.23e-06	0.000555	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	2.21e-06	0.00055	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	2.2e-06	0.000549	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	2.2e-06	0.000548	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	2.19e-06	0.000545	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	2.14e-06	0.000533	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	2.08e-06	0.000517	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	2.08e-06	0.000517	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL3—Crohn's disease	2.02e-06	0.000504	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	2e-06	0.000498	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	2e-06	0.000497	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	2e-06	0.000497	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	1.99e-06	0.000495	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.96e-06	0.000488	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	1.93e-06	0.00048	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	1.92e-06	0.000479	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	1.9e-06	0.000474	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL3—Crohn's disease	1.88e-06	0.000468	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	1.83e-06	0.000455	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.82e-06	0.000453	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	1.82e-06	0.000452	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.81e-06	0.000451	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.78e-06	0.000443	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.77e-06	0.000442	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	1.72e-06	0.000429	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.69e-06	0.000421	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.68e-06	0.000419	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	1.66e-06	0.000413	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.65e-06	0.000411	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	1.65e-06	0.00041	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.62e-06	0.000404	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.61e-06	0.000402	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	1.6e-06	0.000398	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.59e-06	0.000395	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	1.57e-06	0.000391	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.53e-06	0.000381	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.51e-06	0.000375	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	1.5e-06	0.000373	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.47e-06	0.000367	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	1.42e-06	0.000354	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.42e-06	0.000353	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	1.37e-06	0.000341	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	1.36e-06	0.000338	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	1.32e-06	0.000328	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	1.29e-06	0.000322	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	1.18e-06	0.000294	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—Crohn's disease	1.14e-06	0.000284	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	1.12e-06	0.00028	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	1.12e-06	0.000279	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	1.07e-06	0.000267	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	9.99e-07	0.000249	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—Crohn's disease	9.97e-07	0.000248	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	9.79e-07	0.000244	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	9.53e-07	0.000237	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	9.49e-07	0.000236	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	9.31e-07	0.000232	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	9.28e-07	0.000231	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	8.85e-07	0.000221	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	8.7e-07	0.000217	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	8.27e-07	0.000206	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	8.08e-07	0.000201	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—Crohn's disease	8.07e-07	0.000201	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—Crohn's disease	7.88e-07	0.000196	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	7.87e-07	0.000196	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	7.68e-07	0.000191	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—Crohn's disease	7.42e-07	0.000185	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—Crohn's disease	7.06e-07	0.000176	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	6.99e-07	0.000174	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—Crohn's disease	6.89e-07	0.000172	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—Crohn's disease	6.63e-07	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	6.5e-07	0.000162	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.49e-07	0.000162	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—Crohn's disease	5.5e-07	0.000137	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—Crohn's disease	4.89e-07	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—Crohn's disease	4.54e-07	0.000113	CbGpPWpGaD
